Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 849440-33-1 | MDL No. : | MFCD09841968 |
Formula : | C16H23NO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | YTXNDRYCIWRWPG-ZDUSSCGKSA-N |
M.W : | 293.36 | Pubchem ID : | 12148557 |
Synonyms : |
|
Num. heavy atoms : | 21 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.5 |
Num. rotatable bonds : | 7 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 81.27 |
TPSA : | 75.63 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.79 cm/s |
Log Po/w (iLOGP) : | 2.33 |
Log Po/w (XLOGP3) : | 3.24 |
Log Po/w (WLOGP) : | 2.82 |
Log Po/w (MLOGP) : | 2.47 |
Log Po/w (SILICOS-IT) : | 2.7 |
Consensus Log Po/w : | 2.71 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -3.45 |
Solubility : | 0.104 mg/ml ; 0.000355 mol/l |
Class : | Soluble |
Log S (Ali) : | -4.5 |
Solubility : | 0.00924 mg/ml ; 0.0000315 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -3.94 |
Solubility : | 0.0335 mg/ml ; 0.000114 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.91 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 321983-19-1 ]
1-(tert-Butoxycarbonyl)-3-phenylpiperidine-2-carboxylic acid
Similarity: 0.88
[ 1426129-50-1 ]
(R)-tert-Butyl (1-([1,1'-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate
Similarity: 0.86
[ 144163-85-9 ]
tert-Butyl ((2S,4S,5S)-5-amino-4-hydroxy-1,6-diphenylhexan-2-yl)carbamate
Similarity: 0.82
[ 151838-62-9 ]
2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
Similarity: 0.88
[ 321983-19-1 ]
1-(tert-Butoxycarbonyl)-3-phenylpiperidine-2-carboxylic acid
Similarity: 0.88
[ 1426129-50-1 ]
(R)-tert-Butyl (1-([1,1'-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate
Similarity: 0.86
[ 166591-85-1 ]
2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid
Similarity: 0.85
[ 151004-96-5 ]
(R)-2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid
Similarity: 0.85
[ 1426129-50-1 ]
(R)-tert-Butyl (1-([1,1'-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate
Similarity: 0.86
[ 67341-01-9 ]
tert-Butyl (2-hydroxy-1-phenylethyl)carbamate
Similarity: 0.82
[ 144163-85-9 ]
tert-Butyl ((2S,4S,5S)-5-amino-4-hydroxy-1,6-diphenylhexan-2-yl)carbamate
Similarity: 0.82
[ 151838-62-9 ]
2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
Similarity: 0.88
[ 321983-19-1 ]
1-(tert-Butoxycarbonyl)-3-phenylpiperidine-2-carboxylic acid
Similarity: 0.88
[ 166591-85-1 ]
2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid
Similarity: 0.85
[ 151004-96-5 ]
(R)-2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid
Similarity: 0.85